Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

889
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
889
Glaucoma: Overview01:25

Glaucoma: Overview

981
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
981

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Multidisciplinary Consensus-Informed Guidance for the Management of Paediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral Hospitals.

Journal of paediatrics and child health·2026
Same author

Acute Infusion Pain Reaction Due to Anti-PD-1 Antibodies for the Treatment of Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa: A Case Report and Review of the Literature.

Case reports in dermatological medicine·2025
Same author

NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDY.

Retina (Philadelphia, Pa.)·2024
Same author

Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma.

American journal of ophthalmology·2024
Same author

HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents.

Retina (Philadelphia, Pa.)·2024
Same author

Naevoid miliaria profunda, successfully treated with botulinum toxin.

The Australasian journal of dermatology·2024

Related Experiment Video

Updated: Oct 17, 2025

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

9.0K

Infantile hemangioma affecting the iris.

Susan J Robertson1,2, James E Elder3,4, Philip S Bekhor1,4

  • 1Department of Dermatology, The Royal Children's Hospital, Parkville, Victoria, Australia.

Pediatric Dermatology
|October 11, 2021
PubMed
Summary
This summary is machine-generated.

A rare iris hemangioma in an infant girl, alongside skin hemangiomas, highlights the need for visceral screening. Oral propranolol effectively treated all hemangiomas without complications.

Keywords:
hemangiomas/vascular tumorsneonatalneoplasms-benignskin signs of systemic diseasetherapy-systemic

More Related Videos

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.5K
Assessment and Characterization of Hyaloid Vessels in Mice
08:22

Assessment and Characterization of Hyaloid Vessels in Mice

Published on: May 15, 2019

9.4K

Related Experiment Videos

Last Updated: Oct 17, 2025

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

9.0K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.5K
Assessment and Characterization of Hyaloid Vessels in Mice
08:22

Assessment and Characterization of Hyaloid Vessels in Mice

Published on: May 15, 2019

9.4K

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Dermatology

Background:

  • Infantile hemangiomas are common, but intraocular involvement, particularly iris hemangiomas, is rare.
  • Intraocular hemangiomas often signify neonatal hemangiomatosis, increasing the risk of visceral lesions.
  • Concurrent diffuse cutaneous infantile hemangiomas and iris hemangiomas present a unique clinical scenario.

Purpose of the Study:

  • To report a rare case of concurrent iris and diffuse cutaneous infantile hemangiomas.
  • To emphasize the importance of visceral screening in infants with intraocular hemangiomas.
  • To evaluate the efficacy of oral propranolol in treating such lesions.

Main Methods:

  • A case study of an infant girl presenting with iris and cutaneous hemangiomas.
  • Clinical observation and diagnosis of infantile hemangiomas.
  • Treatment initiated with oral propranolol.

Main Results:

  • The infant presented with a left iris hemangioma and diffuse cutaneous infantile hemangiomas from day 2 of life.
  • Oral propranolol administration led to rapid and complete resolution of all hemangiomas.
  • No complications were observed during or after treatment.

Conclusions:

  • Iris hemangiomas, though rare, require thorough evaluation for associated visceral involvement.
  • Early diagnosis and prompt treatment with oral propranolol can be highly effective for infantile hemangiomas, including intraocular types.
  • This case underscores the critical role of comprehensive screening in managing neonatal hemangiomatosis.